• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TRI-LOBE BALLOON CATHETER (MODIFIED); CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TRI-LOBE BALLOON CATHETER (MODIFIED); CATHETER, PERCUTANEOUS Back to Search Results
Catalog Number BCL2645J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Aortic Dissection (2491)
Event Date 09/15/2018
Event Type  Death  
Manufacturer Narrative
A review of the manufacturing records for the gore® tri-lobe balloon catheter could not be performed as device lot/serial number is not available.Per the gore® tri-lobe balloon catheter instructions for use, adverse events which may require intervention include, but are not limited to trauma to the vessel wall, including spasm, dissection, perforation or rupture, and death.
 
Event Description
On (b)(6) 2018, the patient underwent treatment of a ruptured acute stanford type b aortic dissection with two conformable gore® tag® thoracic endoprostheses.The primary entry tear was located approximately 3 cm distal to the left subclavian artery.The distal endoprosthesis was implanted covering the re-entry tear.The proximal endoprosthesis was implanted just distal to the left common carotid artery, intentionally covering the left subclavian artery.Post-implant ballooning was performed on the proximal end of the stent-graft system with a gore® tri-lobe balloon catheter (bcl2645j/lot unknown; volume of balloon inflation is unknown).After a final procedural angiograph was performed, the patient reportedly went into hemorrhagic shock as the incision was being closed.Angiography was performed again, and a retrograde type a dissection was reportedly identified in the ascending aorta.Bleeding in the thoracic cavity due to a perforation of the ascending aorta was also reported.The physician was not able to render any treatment for the dissection and perforation.The procedure was concluded and patient was transferred to the intensive care unit with percutaneous cardiopulmonary support.The patient reportedly expired shortly afterward.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TRI-LOBE BALLOON CATHETER (MODIFIED)
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
damon jackson
1500 n. 4th street
9285263030
MDR Report Key7948514
MDR Text Key123128007
Report Number3007284313-2018-00284
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K081799
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberBCL2645J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Other;
Patient Age80 YR
-
-